COMPANY PROFILE // THE 014 REPORT
Volitionrx Ltd
VNRX (NYSE) · Formerly: STANDARD CAPITAL CORP
Assembled from 2 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-11-12: a pattern of leadership change.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-04-23 and 1 more time (last 24 months).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
VOLITIONRX LTD is an SEC-registered operating company in in vitro & in vivo diagnostic substances, incorporated in DE, based in Henderson, NV; listed as VNRX (NYSE).[source] It reported revenue of $1.7 million for the fiscal year ended 2025-12-31.[source] It has filed 95 documents with the SEC in the last 12 months; the latest is Form 10-Q, filed 2026-11-12.[source] Its largest institutional holders on 13F filings are Lagoda Investment Management, L.P., LUMINUS MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; 3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-11-12.[source]
- red0
- amber2
- info0
- Lagoda Investment Management, L.P.$2.0M
- LUMINUS MANAGEMENT LLC$212K
- GEODE CAPITAL MANAGEMENT, LLC$75K
- VANGUARD CAPITAL MANAGEMENT LLC$68K
- Wealthspire Advisors, LLC$61K
- STATE STREET CORP$46K
- XTX Topco Ltd$34K
- VANGUARD FIDUCIARY TRUST CO$34K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Batchelor Ann-Louise · Group Chief Marketing Officer (Officer) · latest Form 4 2026-02-27 · filing · LinkedIn search
- Butera Salvatore Thomas · CEO - Volition Veterinary (Officer) · latest Form 4 2026-01-23 · filing · LinkedIn search
- Forterre Gael · Chief Commercial Officer (Officer) · latest Form 4 2026-03-19 · filing · LinkedIn search
- Hughes Terig · Chief Financial Officer (Officer) · latest Form 4 2026-02-27 · filing · LinkedIn search
- Kway Jasmine · CEO - Singapore Volition (Officer) · latest Form 4 2026-02-27 · filing · LinkedIn search
- Micallef Jacob Vincent · Chief Scientific Officer (Officer) · latest Form 4 2026-03-19 · filing · LinkedIn search
- Michel Gaetan · Chief Operating Officer (Officer) · latest Form 4 2025-10-07 · filing · LinkedIn search
- Plummer Nicholas · GC - Volition Diagnostics (Officer) · latest Form 4 2026-03-19 · filing · LinkedIn search
- Retter Andrew · Chief Medical Officer (Officer) · latest Form 4 2025-11-04 · filing · LinkedIn search
- Reynolds Cameron John · President and CEO (Director,Officer) · latest Form 4 2026-02-27 · filing · LinkedIn search
- Rootsaert Rodney Gerard · Secretary (Officer) · latest Form 4 2026-03-19 · filing · LinkedIn search
- Barnes Phillip · Director · latest Form 4 2026-01-23 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000093314 | source |
| EIN | 91-1949078 | source |
| NY DOS ID | 4897696 | record |
| NY DOS IDpossible match | 5065858 | record |
| Connecticut business IDpossible match | 519898 | record |
| Business address (SEC) | 1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, 89014 | source |
Does not exist in the records we hold: LEI, UEI, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2835 (in vitro & in vivo diagnostic substances): 21 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- Lantheus Holdings, Inc. · 84 SEC filings in 12 months · 1 flag · $156.2M federal (possible match)
- NEOGEN CORP · 77 SEC filings in 12 months · 3 flags · $3.0M federal (possible match)
- ACHIEVE LIFE SCIENCES, INC. · 75 SEC filings in 12 months · 2 flags · $2.5M federal (possible match)
- TRINITY BIOTECH PLC · 78 SEC filings in 12 months · 1 flag · $422K federal (possible match)
- QuidelOrtho Corp · 105 SEC filings in 12 months · 2 flags · $20K federal (possible match)
- Alpha Teknova, Inc. · 22 SEC filings in 12 months · $15K federal (possible match)
- VOLITIONRX LTD · 95 SEC filings in 12 months · 2 flags
- IDEXX LABORATORIES INC /DE · 80 SEC filings in 12 months · 1 flag
- Intellia Therapeutics, Inc. · 73 SEC filings in 12 months · 2 flags
- IMMUCELL CORP /DE/ · 48 SEC filings in 12 months · 1 flag
- Aspira Women's Health Inc. · 46 SEC filings in 12 months · 6 flags
- Virax Biolabs Group Ltd · 41 SEC filings in 12 months
ADDRESS · ZIP CODE
Location context
At the same address (7)
- MISE EN PLACE · IRS-registered organization
- WELLNESS AND EDUCATION CENTERS OF NEVADA INC · IRS-registered organization
- TIGERS BASEBALL LV · IRS-registered organization
- BAJA PESCADOR INC · IRS-registered organization
- SENIOR RESOURCE NEVADA · IRS-registered organization
- EXECUTIVE WOMENS GOLF ASSOCIATION · IRS-registered organization
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-11-12 officer change 8-K items 5.02 · SEC EDGAR
- 2026-11-12 name change Name changed from VOLITIONRX LTD · SEC EDGAR
- 2026-10-27 filing 8-K items 1.01,8.01,9.01 · SEC EDGAR
- 2026-09-25 filing 8-K items 3.02 · SEC EDGAR
- 2026-09-16 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-09-15 filing 8-K items 3.02 · SEC EDGAR
- 2026-09-14 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-09-09 filing EFFECT · SEC EDGAR
- 2026-09-09 filing S-3/A · SEC EDGAR
- 2026-09-08 filing S-3/A · SEC EDGAR
- 2026-09-04 filing SCHEDULE 13D · SEC EDGAR
- 2026-09-02 filing 8-K items 1.01,9.01 · SEC EDGAR
- 2026-09-02 filing 8-K items 3.02 · SEC EDGAR
- 2026-08-28 filing S-3 · SEC EDGAR
- 2026-08-24 filing 8-K items 3.02 · SEC EDGAR
- 2026-08-21 filing S-8 · SEC EDGAR
- 2026-08-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-13 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-07 filing 8-K items 3.02 · SEC EDGAR
- 2026-07-21 filing 8-K items 5.03,5.07,9.01 · SEC EDGAR
- 2026-07-17 filing EFFECT · SEC EDGAR
- 2026-07-10 filing S-3 · SEC EDGAR
- 2026-06-18 filing 8-K items 3.02 · SEC EDGAR
- 2026-06-10 filing 8-K items 1.01,8.01,9.01 · SEC EDGAR
- 2026-06-09 filing 424B5 · SEC EDGAR
- 2026-06-05 filing 424B5 · SEC EDGAR
- 2026-06-02 filing Proxy statement · SEC EDGAR
- 2026-05-22 filing 8-K items 1.01 · SEC EDGAR
120 earlier entries
- 2026-05-15 officer change 8-K items 5.02
- 2026-05-14 filing Quarterly report (10-Q)
- 2026-05-14 filing 8-K items 2.02,9.01
- 2026-05-13 filing PRE 14A
- 2026-04-30 filing 10-K/A
- 2026-04-28 filing 8-K items 3.03,5.03,9.01
- 2026-04-23 filing 8-K items 3.01,8.01,9.01
- 2026-04-17 filing 8-K items 8.01
- 2026-04-01 filing 8-K items 5.07
- 2026-03-31 filing Annual report (10-K)
- 2026-03-31 filing 8-K items 2.02,9.01
- 2026-02-20 filing 8-K items 3.02,9.01
- 2026-02-19 filing EFFECT
- 2026-02-17 filing CORRESP
- 2026-02-13 filing UPLOAD
- 2026-02-11 filing Proxy statement
- 2026-02-09 filing 8-K items 3.01,8.01,9.01
- 2026-02-09 filing S-3
- 2026-01-28 filing D/A
- 2026-01-26 filing PRE 14A
- 2026-01-23 insider First Form 3/4/5 on record for Barnes Phillip (Director)
- 2026-01-23 insider First Form 3/4/5 on record for Colman Alan (Director)
- 2026-01-23 insider First Form 3/4/5 on record for Henshall Mickie (Director)
- 2026-01-08 filing 8-K items 1.01,3.02,9.01
- 2025-12-11 officer change 8-K items 5.02
- 2025-11-13 filing Quarterly report (10-Q)
- 2025-11-13 filing 8-K items 2.02,9.01
- 2025-11-13 filing 8-K/A items 1.01,9.01
- 2025-11-10 filing 8-K/A items 1.01,9.01
- 2025-11-07 filing 8-K items 1.01,9.01
- 2025-10-15 insider First Form 3/4/5 on record for STILL TIMOTHY I (Director)
- 2025-10-14 filing 8-K items 1.01,2.02,7.01,9.01
- 2025-10-14 filing 424B5
- 2025-10-09 filing 424B5
- 2025-08-15 filing 10-Q/A
- 2025-08-14 filing Quarterly report (10-Q)
- 2025-08-14 filing 8-K items 2.02,9.01
- 2025-08-14 filing 424B5
- 2025-08-04 filing 8-K items 1.01,8.01,9.01
- 2025-08-04 filing 424B5
- 2025-07-14 filing EFFECT
- 2025-07-10 filing CORRESP
- 2025-07-10 filing UPLOAD
- 2025-07-03 filing S-3
- 2025-06-20 filing 8-K items 5.03,5.07,9.01
- 2025-06-04 insider First Form 3/4/5 on record for Innes Guy Archibald (Director)
- 2025-06-03 insider First Form 3/4/5 on record for Batchelor Ann-Louise (Group Chief Marketing Officer)
- 2025-06-03 insider First Form 3/4/5 on record for Hughes Terig (Chief Financial Officer)
- 2025-06-03 insider First Form 3/4/5 on record for Kway Jasmine (CEO - Singapore Volition)
- 2025-06-03 insider First Form 3/4/5 on record for Plummer Nicholas (GC - Volition Diagnostics)
- 2025-06-03 insider First Form 3/4/5 on record for Nguyen Kim (Director)
- 2025-06-03 insider First Form 3/4/5 on record for Rubin Ethel (Director)
- 2025-05-30 filing D
- 2025-05-19 insider First Form 3/4/5 on record for Reynolds Cameron John (President and CEO)
- 2025-05-15 filing Quarterly report (10-Q)
- 2025-05-15 filing 8-K items 2.02,9.01
- 2025-05-05 insider First Form 3/4/5 on record for Butera Salvatore Thomas (CEO - Volition Veterinary)
- 2025-05-05 insider First Form 3/4/5 on record for Forterre Gael (Chief Commercial Officer)
- 2025-05-05 insider First Form 3/4/5 on record for Micallef Jacob Vincent (Chief Scientific Officer)
- 2025-05-05 insider First Form 3/4/5 on record for Michel Gaetan (Chief Operating Officer)
- 2025-05-05 insider First Form 3/4/5 on record for Retter Andrew (Chief Medical Officer)
- 2025-05-05 insider First Form 3/4/5 on record for Rootsaert Rodney Gerard (Secretary)
- 2025-04-29 filing Proxy statement
- 2025-04-25 filing RW WD
- 2025-04-22 filing 8-K items 1.01,1.02,9.01
- 2025-04-22 filing 424B5
- 2025-04-18 filing EFFECT
- 2025-04-16 filing CORRESP
- 2025-04-16 filing RW
- 2025-04-15 filing EFFECT
- 2025-04-11 filing S-3/A
- 2025-04-11 filing CORRESP
- 2025-04-10 filing UPLOAD
- 2025-04-04 filing 8-K items 7.01
- 2025-04-04 filing Registration (S-1)
- 2025-04-04 filing PRE 14A
- 2025-03-31 filing Annual report (10-K)
- 2025-03-31 filing 8-K items 2.02,9.01
- 2025-03-26 filing 8-K items 1.01,8.01,9.01
- 2025-03-26 filing 424B5
- 2024-12-09 filing 8-K items 1.01,8.01,9.01
- 2024-12-09 filing 424B5
- 2024-11-15 filing UPLOAD
- 2024-11-14 filing Quarterly report (10-Q)
- 2024-11-14 filing 8-K items 2.02,9.01
- 2024-11-08 filing S-3
- 2024-11-06 officer change 8-K items 5.02,9.01
- 2024-09-30 officer change 8-K items 5.02,9.01
- 2024-09-27 officer change 8-K items 5.02
- 2024-09-16 filing 8-K items 7.01,9.01
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-08-14 filing 8-K items 2.02,9.01
- 2024-08-12 filing 8-K items 1.01,8.01,9.01
- 2024-08-12 filing 424B5
- 2024-07-24 filing S-8
- 2024-07-03 officer change 8-K items 5.02,5.03,5.07,9.01
- 2024-06-27 filing 8-K items 7.01,9.01
- 2024-06-25 filing EFFECT
- 2024-06-25 filing 424B3
- 2024-06-21 filing CORRESP
- 2024-06-20 filing UPLOAD
- 2024-06-14 filing S-3
- 2024-05-13 filing Proxy statement
- 2024-05-13 filing Quarterly report (10-Q)
- 2024-05-13 filing 8-K items 2.02,9.01
- 2024-04-26 filing PRE 14A
- 2024-04-26 officer change 8-K items 5.02,5.03,9.01
- 2024-03-26 filing D
- 2024-03-25 filing Annual report (10-K)
- 2024-03-25 filing 8-K items 2.02,9.01
- 2024-03-19 filing 8-K items 8.01,9.01
- 2024-02-09 filing SC 13D/A
- 2024-01-03 filing UPLOAD
- 2024-01-02 filing 8-K items 8.01
- 2023-12-20 filing CORRESP
- 2023-12-15 filing UPLOAD
- 2023-12-05 filing 8-K items 8.01,9.01
- 2023-11-14 filing Quarterly report (10-Q)
- 2023-11-14 filing 8-K items 2.02,9.01
- 2011-09-29 name change Name changed from STANDARD CAPITAL CORP
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-12 (within 30 days) 10-Q filed (FORM 10-Q)
- 2026-11-12 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-11-12 (within 30 days) 8-K filed: Item 5.02 officer or director change
- 2026-10-27 (within 30 days) 8-K filed: Item 1.01 material agreement; Item 8.01 other event; Item 9.01 exhibits
- 2026-09-25 (older) 8-K filed: Item 3.02 unregistered equity sale
- 2026-09-15 (older) 8-K filed: Item 3.02 unregistered equity sale
- 2026-09-14 (older) 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-09-09 (older) EFFECT filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NYSE:VNRX The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
3 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 93314 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | VNRX / NYSE | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 911949078 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000093314 | SEC EDGAR / IRS |
| CUSIP | 928661206 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000093314 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $1,727,384 | 2025-12-31 | 10-K, XBRL Revenues | as filed | 2026-11-20 01:37 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$23,357,027 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 01:37 UTC | Report an error |
| Total assets (at 2025-12-31) | $6,901,227 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 01:37 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | -$34,246,393 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 01:37 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $1,117,028 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 01:37 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 01:37 UTC | Report an error |
| SIC industry | 2835 In Vitro & In Vivo Diagnostic Substances | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 01:37 UTC | Report an error |
| State of incorporation | DE | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 01:37 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 01:37 UTC | Report an error |
| Business address | 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 01:37 UTC | Report an error |
| Exchanges | NYSE | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 01:37 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$19,683,334 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 01:37 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $89,558 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 01:37 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $6,708,925 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-20 01:37 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $526,894 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 01:37 UTC | Report an error |
| Form D total offering amount (D/A filed 2026-01-28) | $22,650,000 | 2026-01-28 | D/A | as filed | 2026-11-20 01:37 UTC | Report an error |
| Form D total amount sold (D/A filed 2026-01-28) | $22,650,000 | 2026-01-28 | D/A | as filed | 2026-11-20 01:37 UTC | Report an error |
| Form D industry group | Biotechnology | 2026-01-28 | D/A | as filed | 2026-11-20 01:37 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2026-01-28 | D/A | as filed | 2026-11-20 01:37 UTC | Report an error |
| Form D date of first sale | 2025-05-20 | 2026-01-28 | D/A | as filed | 2026-11-20 01:37 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001477932-26-006881
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $1,613,876 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Net income (loss) | -$3,799,591 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Interest expense | $142,816 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Cash and cash equivalents | $2,400,000 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Debt due in the next 12 months | $2,621,256 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Debt due in year 2 | $3,524,507 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Debt due in year 3 | $287,641 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Debt due in year 4 | $260,535 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
| Debt due after year 5 | $8,168,598 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001477932-26-006881 | 2026-11-20 01:37 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-12 Filing 10-Q filed (FORM 10-Q)
- 2026-11-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-11-12 Filing 8-K filed: Item 5.02 officer or director change
- 2026-10-27 Filing 8-K filed: Item 1.01 material agreement; Item 8.01 other event; Item 9.01 exhibits
- 2026-09-25 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-09-15 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-09-14 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-09-09 Filing EFFECT filed
- 2026-09-09 Filing S-3/A filed (FORM S-3/A)
- 2026-09-08 Filing S-3/A filed (FORM S-3/A)
- 2026-09-02 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-09-02 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-08-28 Filing S-3 filed (FORM S-3)
- 2026-08-24 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-08-21 Filing S-8 filed (FORM S-8)
- 2026-08-13 Filing 10-Q filed (FORM 10-Q)
- 2026-08-13 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-07 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-07-21 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-07-17 Filing EFFECT filed
- 2026-07-10 Filing S-3 filed (FORM S-3)
- 2026-06-18 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-06-10 Filing 8-K filed: Item 1.01 material agreement; Item 8.01 other event; Item 9.01 exhibits
- 2026-06-09 Filing 424B5 filed
- 2026-06-05 Filing 424B5 filed
8-K item text, as filed (excerpts)
- 2026-11-12 8-K Item 2.02, Results of Operations and Financial Condition
The following information, including Exhibit 99.1, is being “furnished” in accordance with General Instruction B.2. of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. On November 12, 2026, VolitionRx Limited (the “Company”) issued a press release announcing its financial results and certain business updates for the quarter ended September 30… the 8-K · retrieved 2026-11-20 01:37 UTC - 2026-10-27 8-K Item 1.01, Entry into a Material Definitive Agreement
As previously reported, VolitionRx Limited (the “Company”) and Lind Global Asset Management XII LLC (“Lind”) entered into a Securities Purchase Agreement, dated May 15, 2025, as amended and restated on January 7, 2026, pursuant to which the Company issued and sold to Lind in addition to certain common stock purchase warrants, a senior secured convertible promissory note issued January 15, 2026 in the original principal amount of $2,400,000 (the “Note”). On October 23, 2026, the Company and Lind entered into a waiver and consent (the “Waiver”) pursuant to which (i) Lind agreed to accept a partial prepayment of outstanding principal by the Company in the amount of $500,000 (the “Partial… the 8-K · retrieved 2026-11-20 01:37 UTC - 2026-10-27 8-K Item 8.01, Other Events
On October 27, 2026, the Company issued a press release announcing the Partial Prepayment and the Waiver. A copy of the press release is included herewith as Exhibit 99.1 and is incorporated herein by reference. the 8-K · retrieved 2026-11-20 01:37 UTC - 2026-09-25 8-K Item 3.02, Unregistered Sales of Equity Securities
Conversions of Note As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC, a Delaware limited liability company (“Lind”), a senior secured convertible promissory note in the original principal amount of $2,400,000. In connection with its obligations under such note, (a) on September 18, 2026 the Company issued to Lind an aggregate of 698,113 shares of common stock to satisfy a $185,000 conversion obligation, and (b) on September 23, 2026 the Company issued to Lind an aggregate of 1,459,227 shares of common… the 8-K · retrieved 2026-11-20 01:37 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Lagoda Investment Management, L.P. | $1,965,533 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 2 | LUMINUS MANAGEMENT LLC | $211,811 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $74,986 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $68,423 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 5 | Wealthspire Advisors, LLC | $60,750 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 6 | STATE STREET CORP | $45,893 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 7 | XTX Topco Ltd | $34,264 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 8 | VANGUARD FIDUCIARY TRUST CO | $33,930 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 9 | BlackRock, Inc. | $30,116 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
| 10 | NORTHERN TRUST CORP | $17,520 | 2026-06-30 | SEC 13F filing | 2026-11-20 01:37 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
3 state and city records carry this company's exact name, from 2 sources. Possible matches only.
New York corporations (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchSTANDARD CAPITAL INC · name equals 'Standard Capital' but other unrelated entities share it · sx:nydos:5065858 Compare
- possible matchVOLITIONRX LIMITED · exact legal name · sx:nydos:4897696 Compare
Connecticut business registrations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchSTANDARD CAPITAL, L.L.C. · name equals 'Standard Capital' but other unrelated entities share it · sx:ctsos:519898 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/93314.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000093314. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.